Porcine pseudorabies virus vaccine composition and preparing method and application thereof

A technology of porcine pseudorabies and vaccine composition, applied in the field of porcine pseudorabies virus vaccine composition and its preparation

Active Publication Date: 2016-01-20
PU LIKE BIO ENG
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After the pigs are immunized with vaccines in the prior art, they cannot completely resist the wild virus attack, and symptoms such as high fever, depression, loss of appetite or extinction will still occur, the infection rate exceeds 80%, the morbidity rate exceeds 30%, and the mortality rate is between 10%. Between 20%
There is no vaccine in the prior art to solve the pseudorabies caused by the variant strain of pseudorabies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Porcine pseudorabies virus vaccine composition and preparing method and application thereof
  • Porcine pseudorabies virus vaccine composition and preparing method and application thereof
  • Porcine pseudorabies virus vaccine composition and preparing method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] The preparation of embodiment 1 porcine pseudorabies virus gB, gD protein

[0072] 1. Amplification of porcine pseudorabies virus gB and gD genes

[0073]Inoculate PRVHN1201 virus or cultures of different generations on well-growing PK15 cells. The cultures of different generations are cultures within 5-35 generations. After harvesting the virus, extract it with the MiniBESTViralRNA / DNAExtractionKitVer.3.0 kit from TAKARA Company PRV genomic DNA. Take 1 μl of genomic DNA as a template, and use gB and gD specific primers respectively:

[0074] gBSF: 5'CTAGGGGGCGTCGGGGTCCTCGT3' and

[0075] gBSR: 5′ATGCCCGCTGGTGGCGGTCTTTGG3′

[0076] gDSF: 5'ATGCTGCTCGCAGCGCTATTGGC3' and

[0077] gDSR: 5′CTACGGACCGGGCTGCGCTTTTAG3′

[0078] Perform PCR amplification using TAKARA's high-fidelity enzymes HSDNAPolymerasewithGCBuffer, gB amplification conditions are: 94°C for 3min; 98°C for 10s, 68°C for 3min, 30cycles; 68°C for 5min, the PCR product is named as gB. The gD amplificatio...

Embodiment 2

[0087] Implementation 2 Preparation of porcine pseudorabies virus vaccine composition

[0088] Take the gB and gD proteins prepared in Example 1, slowly add them to the adjuvant, and continuously stir with an emulsifier at 800 rpm for 12 minutes during the addition process, mix well, and store at 4°C, which is the vaccine composition of porcine pseudorabies virus . See Table 1 for specific ratios.

[0089] Table 1 Porcine pseudorabies virus vaccine composition ratio

[0090]

[0091]

Embodiment 3

[0092] The immunogenicity test of embodiment 3 porcine pseudorabies virus vaccine composition

[0093] 36 PRV antibody-negative piglets at the age of 21 days were randomly divided into 9 groups, 4 heads / group, that is, 1-7 groups were respectively vaccine 1, vaccine 2, vaccine 3, vaccine 4, vaccine 5, and vaccine prepared in Example 1 of the present invention. 6. Vaccine 7 immunization group, the 8th group and 9th group were injected with the same amount of PBS, single immunization. 28 days after immunization, the virus was challenged, and the dose of the virus challenge was 2×10 porcine pseudorabies virus HN1201 strain 8.0 TCID 50 / head, observe the clinical condition and measure the body temperature at a fixed time every day for 7 days after the challenge.

[0094] Results Under the challenge dose, the 4 piglets in the 1st to 7th immunization groups were all protected, showed transient clinical signs and gradually returned to normal after 5 days, and finally survived. Di...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a porcine pseudorabies virus vaccine composition which contains a porcine pseudorabies virus subunit antigen or contains recombined newcastle disease viruses- porcine pseudorabies virus carrier. The invention further provides a preparing method and application for the vaccine composition. The vaccine composition can effectively prevent related diseases of porcine pseudorabies viruses and related infectious diseases caused by the porcine pseudorabies viruses. The combination of the immunogenicity antigen in the porcine pseudorabies virus vaccine composition can induce to generate a synergetic immune effect, the immune effect is good, the immunity use amount is further reduced, and the immunity cost is reduced.

Description

[0001] This application is a divisional application of patent application 201410519314.2, the original filing date is September 30, 2014, and the title of the invention is porcine pseudorabies virus vaccine composition and its preparation method and application. technical field [0002] The invention belongs to the field of veterinary biological products, and in particular relates to a vaccine composition of porcine pseudorabies virus and a preparation method thereof, and the use of the immune antigen in the preparation of prevention and / or treatment of diseases related to porcine pseudorabies virus and porcine pseudorabies virus Use of the composition for infection caused by rabies virus. Background technique [0003] Pseudorabies, also known as Aujeszky's disease, is a kind of pig, cattle, sheep and other domestic animals, poultry and wild animals caused by porcine herpesvirus type Ⅰ (Suidherpesvirus 1 strain) in the α subfamily of Herpesviridae (Herpesviridae) An acute in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/295A61K39/245A61P31/22
Inventor 田克恭孙进忠张超林张许科
Owner PU LIKE BIO ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap